These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36708807)

  • 41. A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.
    Nakano M; Fukami T; Gotoh S; Nakajima M
    J Biol Chem; 2017 Mar; 292(12):4873-4884. PubMed ID: 28188287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A-to-I RNA editing as a tuner of noncoding RNAs in cancer.
    Liao Y; Jung SH; Kim T
    Cancer Lett; 2020 Dec; 494():88-93. PubMed ID: 32822814
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ADAR1 regulates ARHGAP26 gene expression through RNA editing by disrupting miR-30b-3p and miR-573 binding.
    Wang Q; Hui H; Guo Z; Zhang W; Hu Y; He T; Tai Y; Peng P; Wang L
    RNA; 2013 Nov; 19(11):1525-36. PubMed ID: 24067935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human BLCAP transcript: new editing events in normal and cancerous tissues.
    Galeano F; Leroy A; Rossetti C; Gromova I; Gautier P; Keegan LP; Massimi L; Di Rocco C; O'Connell MA; Gallo A
    Int J Cancer; 2010 Jul; 127(1):127-37. PubMed ID: 19908260
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RNA editing in cancer impacts mRNA abundance in immune response pathways.
    Chan TW; Fu T; Bahn JH; Jun HI; Lee JH; Quinones-Valdez G; Cheng C; Xiao X
    Genome Biol; 2020 Oct; 21(1):268. PubMed ID: 33106178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases.
    Yang W; Chendrimada TP; Wang Q; Higuchi M; Seeburg PH; Shiekhattar R; Nishikura K
    Nat Struct Mol Biol; 2006 Jan; 13(1):13-21. PubMed ID: 16369484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.
    Chan TH; Lin CH; Qi L; Fei J; Li Y; Yong KJ; Liu M; Song Y; Chow RK; Ng VH; Yuan YF; Tenen DG; Guan XY; Chen L
    Gut; 2014 May; 63(5):832-43. PubMed ID: 23766440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ADARs and editing: The role of A-to-I RNA modification in cancer progression.
    Fritzell K; Xu LD; Lagergren J; Öhman M
    Semin Cell Dev Biol; 2018 Jul; 79():123-130. PubMed ID: 29146145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells.
    Choudhury Y; Tay FC; Lam DH; Sandanaraj E; Tang C; Ang BT; Wang S
    J Clin Invest; 2012 Nov; 122(11):4059-76. PubMed ID: 23093778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic variation and microRNA targeting of A-to-I RNA editing fine tune human tissue transcriptomes.
    Park E; Jiang Y; Hao L; Hui J; Xing Y
    Genome Biol; 2021 Mar; 22(1):77. PubMed ID: 33685485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
    Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
    BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RNA Editing in Pathogenesis of Cancer.
    Baysal BE; Sharma S; Hashemikhabir S; Janga SC
    Cancer Res; 2017 Jul; 77(14):3733-3739. PubMed ID: 28667076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular diversity through RNA editing: a balancing act.
    Farajollahi S; Maas S
    Trends Genet; 2010 May; 26(5):221-30. PubMed ID: 20395010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adenosine-to-inosine RNA editing.
    Zinshteyn B; Nishikura K
    Wiley Interdiscip Rev Syst Biol Med; 2009; 1(2):202-209. PubMed ID: 20835992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perturbation of biogenesis and targeting of Epstein-Barr virus-encoded miR-BART3 microRNA by adenosine-to-inosine editing.
    Lei T; Yuen KS; Tsao SW; Chen H; Kok KH; Jin DY
    J Gen Virol; 2013 Dec; 94(Pt 12):2739-2744. PubMed ID: 24045110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence.
    Nakano M; Fukami T; Gotoh S; Takamiya M; Aoki Y; Nakajima M
    J Biol Chem; 2016 Jan; 291(2):894-903. PubMed ID: 26601943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Conservation of A-to-I RNA editing in bowhead whale and pig.
    Larsen K; Heide-Jørgensen MP
    PLoS One; 2021; 16(12):e0260081. PubMed ID: 34882682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantification of microRNA editing using two-tailed RT-qPCR for improved biomarker discovery.
    Voss G; Edsjö A; Bjartell A; Ceder Y
    RNA; 2021 Nov; 27(11):1412-1424. PubMed ID: 34433636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
    Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
    Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ASCancer Atlas: a comprehensive knowledgebase of alternative splicing in human cancers.
    Wu S; Huang Y; Zhang M; Gong Z; Wang G; Zheng X; Zong W; Zhao W; Xing P; Li R; Liu Z; Bao Y
    Nucleic Acids Res; 2023 Jan; 51(D1):D1196-D1204. PubMed ID: 36318242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.